Incannex Healthcare (IXHL) Change in Account Payables (2023 - 2024)

Incannex Healthcare's (IXHL) quarterly Change in Account Payables came in at $2.7 million in Q2 2024, up 69.22% year-on-year from $1.6 million in Q3 2023, and up 1447.03% quarter-over-quarter from -$202000.0 in Q1 2024.

Incannex Healthcare (IXHL) Change in Account Payables (2023 - 2024) Analysis & Trends

Incannex Healthcare has disclosed Change in Account Payables across 2 years of filings, most recently posting $2.7 million for Q2 2024.

  • Change in Account Payables for Q2 2024 came in at $2.7 million, up 69.22% year-over-year; the trailing twelve-month figure through Jun 2024 was $4.3 million (changed N/A YoY), and the FY2024 annual result was $3.0 million, up 173.82% from the prior year.
  • Change in Account Payables came in at $2.7 million for Q2 2024 at Incannex Healthcare, up from -$202000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.7 million in Q2 2024 to a low of -$202000.0 in Q1 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 62.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 167.64 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 190,000.00
10 Incannex Healthcare 45.81 Mn 45.81 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 2.72 Mn
Jun 30, 2024 2.72 Mn
Mar 31, 2024 -202,000.00
Mar 31, 2024 -202,000.00
Jun 30, 2023 1.61 Mn
Jun 30, 2023 1.61 Mn
Mar 31, 2023 131,000.00
Mar 31, 2023 131,000.00